ESR1 and breast carcinoma: This suggests an overrepresentation in the feline species of invasive mammary carcinomas in which the ER pathway is poorly functional, and in which Bcl-2 expression does not proceed from estrogen exposure, but rather from other mechanisms still to be determined.